AMENDED AND RESTATED SENIOR SUBORDINATED CONVERTIBLE LOAN AGREEMENT originally dated as of December 31, 2018 and as amended and restated as of January 14, 2019 by and among Melinta Therapeutics, Inc., as the Borrower, the other Loan Parties party...Senior Subordinated Convertible Loan Agreement • January 16th, 2019 • Melinta Therapeutics, Inc. /New/ • Pharmaceutical preparations • New York
Contract Type FiledJanuary 16th, 2019 Company Industry JurisdictionAMENDED AND RESTATED SENIOR SUBORDINATED CONVERTIBLE LOAN AGREEMENT (this “Agreement”), originally dated as of December 31, 2018 and as amended and restated as of January 14, 2019, by and among Melinta Therapeutics, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time and the lenders party hereto from time to time (together with their successors and permitted assigns, the “Lenders”).
FIRST AMENDMENT TO FACILITY AGREEMENTFacility Agreement • January 16th, 2019 • Melinta Therapeutics, Inc. /New/ • Pharmaceutical preparations • New York
Contract Type FiledJanuary 16th, 2019 Company Industry JurisdictionThis FIRST AMENDMENT TO FACILITY AGREEMENT (this “Amendment”) is entered into as of January 14, 2019, by and among MELINTA THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the other Loan Parties party hereto, the Lenders party hereto and Cortland Capital Market Services LLC, as agent for itself and the Secured Parties (in such capacity, together with its successors and assigns in such capacity, “Agent”).